(Q36155132)

English

Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study (English)

1 reference

Europe PubMed Central

12 August 2017

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

9

object named as

K Scott Baker

1 reference

Europe PubMed Central

12 August 2017

2

object named as

Kirsten K Ness

1 reference

Europe PubMed Central

12 August 2017

author name string

Navneet S Majhail

1

1 reference

Europe PubMed Central

12 August 2017

Linda J Burns

3

1 reference

Europe PubMed Central

12 August 2017

Can-Lan Sun

4

1 reference

Europe PubMed Central

12 August 2017

Andrea Carter

5

1 reference

Europe PubMed Central

12 August 2017

Liton Francisco

6

1 reference

Europe PubMed Central

12 August 2017

Stephen J Forman

7

1 reference

Europe PubMed Central

12 August 2017

Smita Bhatia

8

1 reference

Europe PubMed Central

12 August 2017

publication date

20 July 2007

1 reference

Europe PubMed Central

12 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

12 August 2017

13

1 reference

Europe PubMed Central

12 August 2017

10

1 reference

Europe PubMed Central

12 August 2017

1153-1159

1 reference

Europe PubMed Central

12 August 2017

Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 October 2017

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transpla

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 October 2017

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 October 2017

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 October 2017

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 October 2017

Longitudinal data analysis for discrete and continuous outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 October 2017

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

2 July 2018

Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Decreased bone mineral density is common after autologous blood or marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Validation of self-reported complications by bone marrow transplantation survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

23 September 2018

Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083636

5 December 2018

Long-term cause-specific mortality of patients treated for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late cardiotoxicity after treatment for Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery after stem-cell transplantation for hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17889351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2007.06.003

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36155132&oldid=1961364497"